{
  "Version": 75,
  "Individuals": [
    {
      "Name": "European (P-gp modified, CYP3A4 36 h)",
      "Seed": 17189110,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Parameters": [
        {
          "Path": "Organism|Liver|EHC continuous fraction",
          "Value": 1.0,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          },
          "Parameters": [
            {
              "Name": "t1/2 (liver)",
              "Value": 36.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "AADAC",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "BloodCells",
              "Value": 3.9102564103E-05
            },
            {
              "Name": "Plasma",
              "Value": 3.9102564103E-05
            },
            {
              "Name": "Bone",
              "Value": 4.8717948718E-05
            },
            {
              "Name": "Brain",
              "Value": 3.9743589744E-05
            },
            {
              "Name": "Gonads",
              "Value": 0.0011923076923
            },
            {
              "Name": "Heart",
              "Value": 0.0026602564103
            },
            {
              "Name": "Kidney",
              "Value": 5.7051282051E-05
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.0269230769
            },
            {
              "Name": "Muscle",
              "Value": 0.00020833333333
            },
            {
              "Name": "Pancreas",
              "Value": 0.1474358974
            },
            {
              "Name": "Spleen",
              "Value": 0.00037115384615
            },
            {
              "Name": "Stomach",
              "Value": 0.0775641026
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.2544871795
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.00010384615385
            },
            {
              "Name": "Duodenum",
              "Value": 0.2544871795
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.2544871795
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.2544871795
            },
            {
              "Name": "UpperIleum",
              "Value": 0.2544871795
            },
            {
              "Name": "LowerIleum",
              "Value": 0.2544871795
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.00010384615385
            }
          ]
        },
        {
          "Name": "P-gp",
          "Type": "Transporter",
          "TransportType": "Efflux",
          "Expression": [
            {
              "Name": "Bone",
              "MembraneLocation": "Basolateral",
              "Value": 0.0341950646
            },
            {
              "Name": "Brain",
              "MembraneLocation": "BloodBrainBarrier",
              "Value": 0.1072855464
            },
            {
              "Name": "Gonads",
              "MembraneLocation": "Basolateral",
              "Value": 0.024559342
            },
            {
              "Name": "Heart",
              "MembraneLocation": "Basolateral",
              "Value": 0.059106933
            },
            {
              "Name": "Kidney",
              "MembraneLocation": "Apical",
              "Value": 1.0
            },
            {
              "Name": "Periportal",
              "MembraneLocation": "Apical",
              "Value": 0.2702702703
            },
            {
              "Name": "Pericentral",
              "MembraneLocation": "Apical",
              "Value": 0.2702702703
            },
            {
              "Name": "Lung",
              "MembraneLocation": "Basolateral",
              "Value": 0.0927144536
            },
            {
              "Name": "Muscle",
              "MembraneLocation": "Basolateral",
              "Value": 0.0180963572
            },
            {
              "Name": "Pancreas",
              "MembraneLocation": "Basolateral",
              "Value": 0.0200940071
            },
            {
              "Name": "Spleen",
              "MembraneLocation": "Basolateral",
              "Value": 0.1047003525
            },
            {
              "Name": "Stomach",
              "MembraneLocation": "Basolateral",
              "Value": 0.0367802585
            },
            {
              "Name": "SmallIntestine",
              "MembraneLocation": "Basolateral",
              "Value": 0.3960047004
            },
            {
              "Name": "LargeIntestine",
              "MembraneLocation": "Basolateral",
              "Value": 0.1562867215
            },
            {
              "Name": "Duodenum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "UpperJejunum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "LowerJejunum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "UpperIleum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "LowerIleum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "ColonAscendens",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonTransversum",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonDescendens",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonSigmoid",
              "MembraneLocation": "Apical",
              "Value": 0.56
            }
          ],
          "Ontogeny": {
            "Name": "P-gp",
            "Table": {
              "Name": "TableFormula",
              "Percentile": 0.0,
              "DistributionMetaData": [
                {
                  "Mean": 1E-14,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 1.915059E-05,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 5.486795E-05,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.0001571905,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.0004502473,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.001288958,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.00368424,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.01048397,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.02946235,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.0800178,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.1994918,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.4165768,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.6716791,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.8542612,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.943803,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9796414,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.992799,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9974749,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9991173,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9996917,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9998924,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9999624,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9999869,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 1.0,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                }
              ],
              "XName": "Postmenstrual age",
              "XDimension": "Age in years",
              "XUnit": "year(s)",
              "YName": "P-gp",
              "YDimension": "Fraction",
              "UseDerivedValues": false,
              "Points": [
                {
                  "X": 0.0,
                  "Y": 1E-14,
                  "RestartSolver": false
                },
                {
                  "X": 0.08333334,
                  "Y": 1.915059E-05,
                  "RestartSolver": false
                },
                {
                  "X": 0.1666667,
                  "Y": 5.486795E-05,
                  "RestartSolver": false
                },
                {
                  "X": 0.25,
                  "Y": 0.0001571905,
                  "RestartSolver": false
                },
                {
                  "X": 0.3333333,
                  "Y": 0.0004502473,
                  "RestartSolver": false
                },
                {
                  "X": 0.4166667,
                  "Y": 0.001288958,
                  "RestartSolver": false
                },
                {
                  "X": 0.5,
                  "Y": 0.00368424,
                  "RestartSolver": false
                },
                {
                  "X": 0.5833333,
                  "Y": 0.01048397,
                  "RestartSolver": false
                },
                {
                  "X": 0.6666667,
                  "Y": 0.02946235,
                  "RestartSolver": false
                },
                {
                  "X": 0.75,
                  "Y": 0.0800178,
                  "RestartSolver": false
                },
                {
                  "X": 0.8333333,
                  "Y": 0.1994918,
                  "RestartSolver": false
                },
                {
                  "X": 0.9166667,
                  "Y": 0.4165768,
                  "RestartSolver": false
                },
                {
                  "X": 1.0,
                  "Y": 0.6716791,
                  "RestartSolver": false
                },
                {
                  "X": 1.083333,
                  "Y": 0.8542612,
                  "RestartSolver": false
                },
                {
                  "X": 1.166667,
                  "Y": 0.943803,
                  "RestartSolver": false
                },
                {
                  "X": 1.25,
                  "Y": 0.9796414,
                  "RestartSolver": false
                },
                {
                  "X": 1.333333,
                  "Y": 0.992799,
                  "RestartSolver": false
                },
                {
                  "X": 1.416667,
                  "Y": 0.9974749,
                  "RestartSolver": false
                },
                {
                  "X": 1.5,
                  "Y": 0.9991173,
                  "RestartSolver": false
                },
                {
                  "X": 1.583333,
                  "Y": 0.9996917,
                  "RestartSolver": false
                },
                {
                  "X": 1.666667,
                  "Y": 0.9998924,
                  "RestartSolver": false
                },
                {
                  "X": 1.75,
                  "Y": 0.9999624,
                  "RestartSolver": false
                },
                {
                  "X": 1.833333,
                  "Y": 0.9999869,
                  "RestartSolver": false
                },
                {
                  "X": 3.333333,
                  "Y": 1.0,
                  "RestartSolver": false
                }
              ]
            }
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.41,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "OATP1B1",
          "Type": "Transporter",
          "TransportType": "Influx",
          "Expression": [
            {
              "Name": "Brain",
              "MembraneLocation": "BloodBrainBarrier",
              "Value": 0.00014166666667
            },
            {
              "Name": "Gonads",
              "MembraneLocation": "Basolateral",
              "Value": 0.0141666667
            },
            {
              "Name": "Heart",
              "MembraneLocation": "Basolateral",
              "Value": 0.0008253968254
            },
            {
              "Name": "Periportal",
              "MembraneLocation": "Basolateral",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "MembraneLocation": "Basolateral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "MembraneLocation": "Basolateral",
              "Value": 4.0079365079E-05
            },
            {
              "Name": "Muscle",
              "MembraneLocation": "Basolateral",
              "Value": 0.00064682539683
            }
          ]
        },
        {
          "Name": "ATP1A2",
          "Type": "OtherProtein",
          "MembraneLocation": "Apical",
          "TissueLocation": "ExtracellularMembrane",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Bone",
              "Value": 0.0062154033171
            },
            {
              "Name": "Brain",
              "Value": 1.0
            },
            {
              "Name": "Gonads",
              "Value": 0.0508741242
            },
            {
              "Name": "Heart",
              "Value": 0.3179118843
            },
            {
              "Name": "Kidney",
              "Value": 0.0158938619
            },
            {
              "Name": "Periportal",
              "Value": 0.0223784807
            },
            {
              "Name": "Pericentral",
              "Value": 0.0223784807
            },
            {
              "Name": "Lung",
              "Value": 0.0272345453
            },
            {
              "Name": "Muscle",
              "Value": 0.7034193524
            },
            {
              "Name": "Pancreas",
              "Value": 0.0073903254795
            },
            {
              "Name": "Skin",
              "Value": 0.0389467988
            },
            {
              "Name": "Spleen",
              "Value": 0.0103243118
            },
            {
              "Name": "Stomach",
              "Value": 0.0309435884
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0501579923
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.0786998764
            },
            {
              "Name": "Duodenum",
              "Value": 0.0501579923
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0501579923
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0501579923
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0501579923
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0501579923
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.0786998764
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 0.47661714,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "UGT1A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            }
          ],
          "Ontogeny": {
            "Name": "UGT1A4"
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 2.32,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "GABRG2",
          "Type": "OtherProtein",
          "MembraneLocation": "Apical",
          "TissueLocation": "ExtracellularMembrane",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 1.0
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.0877710492,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ]
    }
  ],
  "Compounds": [
    {
      "Name": "Rifampicin",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.5,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "Name": "DrugBank logP",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.7,
              "Unit": "Log Units"
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Templeton 2011",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 17.0,
              "Unit": "%",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Other",
                "Description": "Templeton 2011 (equilibrium dialysis)"
              }
            }
          ]
        },
        {
          "Name": "Baneyx 2013",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 16.0,
              "Unit": "%"
            }
          ]
        },
        {
          "Name": "Boman 1974",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 11.0,
              "Unit": "%"
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous solubility",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 2800.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Database",
                "Description": "DrugBank"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Database",
                "Description": "DrugBank"
              }
            }
          ]
        },
        {
          "Name": "FaSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 450.0,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 6.5
            }
          ]
        },
        {
          "Name": "FeSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 1600.0,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 5.0
            }
          ]
        },
        {
          "Name": "Optimized",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 1211.88,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 7.0
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 1.24E-05,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 7.9,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Type": "Acid",
          "Pka": 1.7,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationSpecific_MM",
          "DataSource": "Nakajima 2011",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "Enzyme concentration",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 6.5,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 195.1,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 9.865,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Collett 2004",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 60.0,
              "Unit": "nmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 2.87,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 55.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 0.6088,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Tirona 2003",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 109.6,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 0.372,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 1.5,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 7.796,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "GFR",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Kajosaari 2005",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 18.5,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Kajosaari et al. 2005"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Reitman 2011",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 169.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Reitman 2011 (IC50 = Ki (169 µM / (1+ (0.1 µM / 177 µM) )"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Templeton 2011",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            },
            {
              "Name": "Emax",
              "Value": 9.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Greiner 1999",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 2.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Greiner et al. 1999"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Dixit 2007",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.383,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Assumed",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.985,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 822.94,
          "Unit": "g/mol"
        }
      ]
    },
    {
      "Name": "Midazolam",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.8972038771,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "Name": "LogP (Simcyp)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.53,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Simcyp"
              }
            }
          ]
        },
        {
          "Name": "LogP (experimental) (Dagenais)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.0,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Dagenais 2009"
              }
            }
          ]
        },
        {
          "Name": "LogP (GastroPlus)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.37,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "GastroPlus"
              }
            }
          ]
        },
        {
          "Name": "LogP (experimental) (Rodgers & Rowland)",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.1,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Rodgers and Rowland"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Simcyp",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.032,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Simcyp"
              }
            }
          ]
        },
        {
          "Name": "Gertz et al. 2010",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.031,
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "Name": "Lown et al. 1995",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.022,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Lown et al. 1995"
              }
            }
          ]
        },
        {
          "Name": "Björkman et al. 2001 (men)",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.016
            }
          ]
        },
        {
          "Name": "Björkman et al. 2001 (women)",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.02
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous solubility",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 0.13,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            }
          ]
        },
        {
          "Name": "FaSSIF",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 0.049,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 6.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            }
          ]
        },
        {
          "Name": "FeSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 0.09,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Heikkinen 2012"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 0.00015549970673,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 6.2
        },
        {
          "Type": "Acid",
          "Pka": 10.95
        }
      ],
      "Processes": [
        {
          "InternalName": "SpecificBinding",
          "DataSource": "Buhr 1997",
          "Molecule": "GABRG2",
          "Parameters": [
            {
              "Name": "koff",
              "Value": 1.0,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "Kd",
              "Value": 1.8,
              "Unit": "nmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Patki et al. 2003",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.18,
              "Unit": "nmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 3.9,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "rCYP450_MM",
          "DataSource": "Simcyp",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax/recombinant enzyme",
              "Value": 2.16,
              "Unit": "pmol/min/pmol rec. enzyme"
            },
            {
              "Name": "Km",
              "Value": 2.16,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Optimized",
          "Molecule": "UGT1A4",
          "Metabolite": "Midazolam-N-glucuronide",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 276.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 58.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Achour 2014"
              }
            },
            {
              "Name": "Km",
              "Value": 37.8,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "kcat",
              "Value": 3.5911771641,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "Optimized",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 0.6401025724,
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Optimized",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 850.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 4.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            },
            {
              "Name": "kcat",
              "Value": 8.7607941215,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'PI Hohmann iv+po, Hyland feUr MDZG, Thummel feUr unchanged - Pint' on 2019-04-09 16:10"
              }
            }
          ]
        },
        {
          "InternalName": "rCYP450_MM",
          "DataSource": "Galentin et al. 2004",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax/recombinant enzyme",
              "Value": 1.96,
              "Unit": "pmol/min/pmol rec. enzyme"
            },
            {
              "Name": "Km",
              "Value": 2.69,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Ito et al. 2003",
          "Molecule": "CYP3A4",
          "Metabolite": "1-OH-Midazolam",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 4.41,
              "Unit": "nmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 3.8,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "GastroPlus",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 850.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Km",
              "Value": 4.0,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Klieber et al. 2008",
          "Molecule": "UGT1A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 276.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 58.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Achour 2014"
              }
            },
            {
              "Name": "Km",
              "Value": 37.8,
              "Unit": "µmol/l"
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Cl",
          "Value": 1.0
        },
        {
          "Name": "F",
          "Value": 1.0
        },
        {
          "Name": "Molecular weight",
          "Value": 325.78,
          "Unit": "g/mol"
        }
      ]
    }
  ],
  "Formulations": [
    {
      "Name": "Tablet (Dormicum)",
      "FormulationType": "Formulation_Tablet_Weibull",
      "Parameters": [
        {
          "Name": "Dissolution time (50% dissolved)",
          "Value": 0.0107481462,
          "Unit": "min",
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'PI Tablet 7.5 mg' on 2019-04-09 16:30"
          }
        },
        {
          "Name": "Lag time",
          "Value": 0.0,
          "Unit": "min"
        },
        {
          "Name": "Dissolution shape",
          "Value": 4.3802943225,
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'PI Tablet 7.5 mg' on 2019-04-09 16:30"
          }
        },
        {
          "Name": "Use as suspension",
          "Value": 1.0
        }
      ]
    },
    {
      "Name": "Oral solution",
      "FormulationType": "Formulation_Dissolved"
    }
  ],
  "Protocols": [
    {
      "Name": "Backman 1996 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1996 - Midazolam - 15 mg (with Perpetrator)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 113.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1996 - Midazolam - 15 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1998 - Midazolam - 15 mg (Phase I Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 113.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 15.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 185.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Backman 1998 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Rifampicin - 600 mg MD OD 8 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 8.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 166.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator) 2",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 166.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Midazolam - 0.075 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Midazolam - 7.5 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.075,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 90.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 114.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Eap 2004 - Rifampicin - 450 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 450.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - po 4 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 4.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Midazolam - po 6 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 6.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gorski 2003 - Rifampicin - 600 mg MD OD 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2006 - Midazolam - po 8 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2006 - Midazolam - po 8 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2006 - Rifampicin - 300 mg MD BID 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2008 - Midazolam - po 8 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2008 - Midazolam - po 8 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 8.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 146.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Gurley 2008 - Rifampicin - 300 mg MD BID 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Midazolam - po 3 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 104.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 128.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - iv 2 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - po 7.5 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - iv 2 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Midazolam - po 7.5 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Tablet (Dormicum)",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 7.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Link 2008 - Rifampicin - 600 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 106.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 648.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 816.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 3",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 984.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 4",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 2.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 1320.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Reitman 2011 - Rifampicin - 600 mg MD OD 28 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 28.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Intravenous",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.05,
                  "Unit": "mg/kg"
                },
                {
                  "Name": "Infusion time",
                  "Value": 30.0,
                  "Unit": "min"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Szalat 2007 - Rifampicin - 600 mg MD OD 7 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 108.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 132.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 5.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 10.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 25.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 75.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Midazolam - po 3 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Oral solution",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 3.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 2011 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 1997 - Midazolam - iv 1 mg (Control)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 1997 - Midazolam - iv 1 mg (with Rifampicin)",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "IntravenousBolus",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 1.0,
                  "Unit": "mg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 600.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    }
  ],
  "Simulations": [
    {
      "Name": "DDI Control - Midazolam - Backman 1996",
      "Model": "4Comp",
      "ObservedData": [
        "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1996 - Midazolam - 15 mg (Control)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1996 - Midazolam - 15 mg (Control)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Backman 1996-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Backman 1996|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|Time",
              "Y": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Control - Backmann 1996\n2019-04-16 13:13"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
      "Model": "4Comp",
      "ObservedData": [
        "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
        "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 209.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)|Tablet (Dormicum)|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1998 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1998 - Midazolam - 15 mg (Phase IV and V with Rifampicin)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Backman 1998 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 182.925186,
              "Max": 192.66893,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.0593922175,
              "Max": 49.5132942,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1998-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1998|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1998-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1998|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
              "Y": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
              "Y": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "0, 0, 255",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Backmann 1998\n2019-04-16 13:30"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Backman 1998",
      "Model": "4Comp",
      "ObservedData": [
        "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1998 - Midazolam - 15 mg (Phase I Control)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1998 - Midazolam - 15 mg (Phase I Control)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Backman 1998-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Backman 1998|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
              "Y": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Control - Backmann 1998\n2019-04-16 13:26"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
      "Model": "4Comp",
      "ObservedData": [
        "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 137.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Backman 1996 - Midazolam - 15 mg (with Perpetrator)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Backman 1996 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Backman 1996 - Midazolam - 15 mg (with Perpetrator)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Backman 1996 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1996-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1996|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Backman 1996-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Backman 1996|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|Time",
              "Y": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Backmann 1996\n2019-04-16 13:09"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
      "Model": "4Comp",
      "ObservedData": [
        "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 190.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Chung 2006 - Rifampicin - 600 mg MD OD 8 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (with Perpetrator)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Chung 2006 - Rifampicin - 600 mg MD OD 8 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Chung 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Chung 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Chung 2006-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Chung 2006|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|Time",
              "Y": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Chung 2006\n2019-04-16 18:28"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Chung 2006",
      "Model": "4Comp",
      "ObservedData": [
        "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Chung 2006 - Midazolam - 0.075 mg/kg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Chung 2006 - Midazolam - 0.075 mg/kg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Chung 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Chung 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|Time",
              "Y": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
      "Model": "4Comp",
      "ObservedData": [
        "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
        "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 137.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Eap 2004 - Rifampicin - 450 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Midazolam - 0.075 and 7.5 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Rifampicin - 450 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Eap 2004-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Eap 2004|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Eap 2004-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Eap 2004|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)-Midazolam-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)|Time",
              "Y": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)-Midazolam-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)|Time",
              "Y": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Eap 2004\n2019-04-17 11:05"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
      "Model": "4Comp",
      "ObservedData": [
        "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Eap 2004 - Midazolam - 0.075 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Midazolam - 0.075 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Eap 2004 (0.075 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Eap 2004 (0.075 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)-Midazolam-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)|Time",
              "Y": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
      "Model": "4Comp",
      "ObservedData": [
        "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Eap 2004 - Midazolam - 7.5 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Eap 2004 - Midazolam - 7.5 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Eap 2004 (7.5 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Eap 2004 (7.5 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)-Midazolam-Peripheral Venous Blood-Plasma-GeometricMean",
              "X": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|Time",
              "Y": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
      "Model": "4Comp",
      "ObservedData": [
        "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - iv 0.05 mg/kg (with Rifampicin)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Rifampicin - 600 mg MD OD 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|Time",
              "Y": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)\n2019-04-17 11:16"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
      "Model": "4Comp",
      "ObservedData": [
        "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - po 6 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gorski 2003 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - po 6 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Rifampicin - 600 mg MD OD 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)|Time",
              "Y": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI2\nDDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)\n2019-05-10 16:45"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gorski 2003 (iv)",
      "Model": "4Comp",
      "ObservedData": [
        "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - iv 0.05 mg/kg (Control)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - iv 0.05 mg/kg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gorski 2003 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gorski 2003 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|Time",
              "Y": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI2\nDDI Control - Midazolam - Gorski 2003 (iv)\n2019-05-10 16:44"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gorski 2003 (po)",
      "Model": "4Comp",
      "ObservedData": [
        "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gorski 2003 - Midazolam - po 4 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gorski 2003 - Midazolam - po 4 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gorski 2003 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gorski 2003 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)-Midazolam-Peripheral Venous Blood-Whole Blood-ArithmeticMean",
              "X": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|Time",
              "Y": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI2\nDDI Control - Midazolam - Gorski 2003 (po)\n2019-05-10 16:44"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gurley 2006",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2006 - Midazolam - po 8 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2006 - Midazolam - po 8 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gurley 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gurley 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
              "Y": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Gurley 2008",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2008 - Midazolam - po 8 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2008 - Midazolam - po 8 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Gurley 2008-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Gurley 2008|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
              "Y": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2006 - Midazolam - po 8 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2006 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2006 - Midazolam - po 8 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2006 - Rifampicin - 300 mg MD BID 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
              "Y": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
      "Model": "4Comp",
      "ObservedData": [
        "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 170.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Gurley 2008 - Midazolam - po 8 mg (with Rifampicin)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Gurley 2008 - Rifampicin - 300 mg MD BID 7 days|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2008 - Midazolam - po 8 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Gurley 2008 - Rifampicin - 300 mg MD BID 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
              "Y": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Gurley 2006\n2019-04-17 11:23"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
        "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 152.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2004 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Rifampicin - 600 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 93.62808,
              "Max": 145.4821,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.07266742,
              "Max": 15175.4,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|Time",
              "Y": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|Time",
              "Y": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "0, 0, 255",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Kharasch 2004\n2019-04-17 11:33"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2004 (iv)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2004 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2004 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|Time",
              "Y": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2004 (po)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2004 - Midazolam - po 3 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2004 - Midazolam - po 3 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2004 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2004 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|Time",
              "Y": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
      "Model": "4Comp",
      "ObservedData": [
        "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Link 2008 - Midazolam - po 7.5 mg (with Rifampicin)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - po 7.5 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Rifampicin - 600 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|Time",
              "Y": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Link 2008 (po)\n2019-04-17 12:21"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
      "Model": "4Comp",
      "ObservedData": [
        "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Link 2008 - Rifampicin - 600 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - iv 2 mg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Rifampicin - 600 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|Time",
              "Y": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)\n2019-04-17 12:20"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Link 2008 (po)",
      "Model": "4Comp",
      "ObservedData": [
        "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Link 2008 - Midazolam - po 7.5 mg (Control)|Tablet (Dormicum)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - po 7.5 mg (Control)",
            "Formulations": [
              {
                "Name": "Tablet (Dormicum)",
                "Key": "Tablet (Dormicum)"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Link 2008 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Link 2008 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|Time",
              "Y": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Link 2008 (iv)",
      "Model": "4Comp",
      "ObservedData": [
        "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Link 2008 - Midazolam - iv 2 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Link 2008 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Link 2008 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|Time",
              "Y": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
      "Model": "4Comp",
      "ObservedData": [
        "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 128.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Phimmasone 2001 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|Time",
              "Y": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Phimmasone 2001\n2019-04-17 12:24"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Phimmasone 2001",
      "Model": "4Comp",
      "ObservedData": [
        "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Phimmasone 2001 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Phimmasone 2001-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Phimmasone 2001|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|Time",
              "Y": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
      "Model": "4Comp",
      "ObservedData": [
        "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 1344.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_16|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_17|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_18|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_19|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_20|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_21|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_22|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_23|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_24|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_25|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_26|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_27|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_28|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Reitman 2011 - Rifampicin - 600 mg MD OD 28 days|Oral solution|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Reitman 2011 - Midazolam - po 2 mg (day 28, 35, 42 and 56)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Reitman 2011 - Rifampicin - 600 mg MD OD 28 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
              "Y": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Reitman 2011\n2019-04-17 12:33"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
      "Model": "4Comp",
      "ObservedData": [
        "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Szalat 2007 - Midazolam - iv 0.05 mg/kg (with Rifampicin)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Szalat 2007 - Rifampicin - 600 mg MD OD 7 days|Oral solution|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Szalat 2007 - Rifampicin - 600 mg MD OD 7 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|Time",
              "Y": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Szalat 2007\n2019-04-17 12:40"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Szalat 2007",
      "Model": "4Comp",
      "ObservedData": [
        "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Szalat 2007 - Midazolam - iv 0.05 mg/kg (Control)|Application_1|ProtocolSchemaItem|Infusion time",
          "Value": 30.0,
          "Unit": "min"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Szalat 2007 - Midazolam - iv 0.05 mg/kg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Szalat 2007-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Szalat 2007|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|Time",
              "Y": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 5 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)\n2019-04-17 12:45"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 10 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "0, 0, 255",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 25 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 156.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days|Oral solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg and po 3 mg (with Rifampicin)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Rifampicin - 75 mg MD OD 6 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2011 (iv)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2011 (iv)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2011 (iv)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 2011 (po)",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 2011 - Midazolam - po 3 mg (Control)|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 2011 - Midazolam - po 3 mg (Control)",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Oral solution"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 2011 (po)-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 2011 (po)|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)-Midazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
              "Y": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Control - Midazolam - Kharasch 1997",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 1997 - Midazolam - iv 1 mg (Control)"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Control - Midazolam - Kharasch 1997-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Control - Midazolam - Kharasch 1997|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|Time",
              "Y": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis"
        }
      ]
    },
    {
      "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
      "Model": "4Comp",
      "ObservedData": [
        "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 152.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h)",
      "Compounds": [
        {
          "Name": "Midazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "FaSSIF",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Gertz et al. 2010",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "UGT1A4-Optimized",
              "MoleculeName": "UGT1A4"
            },
            {
              "Name": "Glomerular Filtration-Optimized"
            },
            {
              "Name": "GABRG2-Buhr 1997",
              "MoleculeName": "GABRG2"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 1997 - Midazolam - iv 1 mg (with Rifampicin)"
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Kharasch 1997 - Rifampicin - 600 mg MD OD 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "White",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997-Midazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997|Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Red",
                "LegendIndex": 1
              }
            },
            {
              "Name": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "Blue",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)-Midazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|Time",
              "Y": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual",
              "CurveOptions": {
                "Color": "255, 0, 0",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Midazolam-DDI\nDDI Treatment - Rifampicin/Midazolam - Kharasch 1997\n2019-05-03 16:57"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    }
  ],
  "ObservedData": [
    {
      "Name": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 53.0
        },
        {
          "Name": "Study Id",
          "Value": "Backman 1996"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/8549036"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "15 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum, tablet"
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "Arith. SEM converted to arith. SD"
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.0100960769,
                0.0240217019,
                0.0146219041,
                0.00939981,
                0.00974792,
                0.008355376,
                0.005222097,
                0.00348140835,
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.00858715549,
            0.04656881,
            0.04348624,
            0.0374311879,
            0.023669729,
            0.01706422,
            0.01045872,
            0.007486238,
            0.00506422,
            0.003302752
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 54.0
        },
        {
          "Name": "Study Id",
          "Value": "Backman 1996"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/8549036"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "15 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum, tablet"
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            1.98165083,
            2.201835,
            2.201835,
            1.761468,
            0.9908258,
            0.6605505,
            0.3302752,
            0.2201835
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0,
          116.0,
          117.0,
          118.0,
          119.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 55.0
        },
        {
          "Name": "Study Id",
          "Value": "Backman 1998"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9591931"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1 & Tab. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Phase I (Control (Perpetrator Placebo))"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "15 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum 7.5-mg tablet, Ho€mann-La Roche"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "Arith. SEM converted to arith. SD"
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                "NaN",
                0.03886638,
                0.0388664119,
                0.03765183,
                0.0340080932,
                0.0291497968,
                0.0218623411,
                0.0157894827,
                "NaN",
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77,
            "LLOQ": 2E-09
          },
          "Values": [
            1.0,
            25.10122,
            47.36842,
            53.84615,
            54.25101,
            45.74899,
            27.12551,
            18.62348,
            14.5749,
            8.906882,
            6.477733
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0,
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 56.0
        },
        {
          "Name": "Study Id",
          "Value": "Backman 1998"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9591931"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1 & Tab. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Phase IV (during Perpetrator (Rifampicin))"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "15 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum 7.5-mg tablet, Ho€mann-La Roche"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77,
            "LLOQ": 2E-09
          },
          "Values": [
            1.0,
            2.024292,
            2.024292,
            1.214575,
            0.8097166
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.0,
          113.5,
          114.0,
          114.5,
          115.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 57.0
        },
        {
          "Name": "Study Id",
          "Value": "Backman 1998"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9591931"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1 & Tab. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Phase V (4 days after Perpetrator (Rifampicin))"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "15 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 185.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum 7.5-mg tablet, Ho€mann-La Roche"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "Arith. SEM converted to arith. SD"
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                "NaN",
                0.01457491,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77,
            "LLOQ": 2E-09
          },
          "Values": [
            1.0,
            10.93117,
            10.12146,
            7.69230747,
            6.477733,
            3.238866,
            1.619433,
            1.214575
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          185.0,
          185.5,
          186.0,
          186.5,
          187.0,
          188.0,
          189.0,
          190.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 112.0
        },
        {
          "Name": "Study Id",
          "Value": "Chung 2006"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/16580903"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 18.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.075 mg/kg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Syrup"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.01244534,
                0.005113894,
                0.004263865,
                0.00511541869,
                0.00324032316,
                0.00204784214,
                0.00102354
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.0223580711,
            0.0184655786,
            0.0145730795,
            0.0110222707,
            0.006135914,
            0.003977728,
            0.002044797
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 113.0
        },
        {
          "Name": "Study Id",
          "Value": "Chung 2006"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/16580903"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 18.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.075 mg/kg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 166.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.001875,
                0.001193182,
                0.00068181823,
                0.000852272962,
                0.000340909377
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            3.579545,
            3.579545,
            2.556818,
            1.363636,
            1.022727
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          166.25,
          166.5,
          167.0,
          167.5,
          168.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 128.0
        },
        {
          "Name": "Study Id",
          "Value": "Eap 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15114429"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "75 micg Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 21.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "75 Âµg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "GeometricStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                1.598724,
                1.332074,
                1.497862,
                1.557589,
                1.821283,
                1.728765,
                1.640946
              ],
              "Dimension": "Dimensionless"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.000243664617,
            0.0002282919,
            0.00016056851,
            0.000105810395,
            6.53272436E-05,
            5.09972961E-05,
            3.82841426E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 132.0
        },
        {
          "Name": "Study Id",
          "Value": "Eap 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15114429"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "7.5 mg with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 4.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "7.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 114.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "GeometricStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                1.184636,
                1.200177,
                1.13921,
                1.200177,
                1.053517,
                1.264407,
                1.297799,
                1.314825
              ],
              "Dimension": "Dimensionless"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            2.824512,
            1.226533,
            0.7474548,
            0.449604,
            0.2500997,
            0.1427963,
            0.06120578,
            0.04476549
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          114.5,
          115.0,
          115.5,
          116.0,
          117.0,
          118.0,
          120.0,
          122.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 131.0
        },
        {
          "Name": "Study Id",
          "Value": "Eap 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15114429"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "7.5 mg Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 13.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "7.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "GeometricStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                1.53742,
                1.367254,
                1.332074,
                1.459321,
                1.598724,
                1.619698,
                1.869382,
                1.893907
              ],
              "Dimension": "Dimensionless"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.02333053,
            0.01598724,
            0.0138519,
            0.0109552611,
            0.007507092,
            0.004882916,
            0.002415566,
            0.001491368
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          6.0,
          8.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 129.0
        },
        {
          "Name": "Study Id",
          "Value": "Eap 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15114429"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "75 micg with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 4.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "75 Âµg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 90.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "GeometricStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                1.169296,
                1.349549,
                2.102042,
                1.248034,
                1.440425,
                "NaN"
              ],
              "Dimension": "Dimensionless"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|GeometricMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.04968513,
            0.06364636,
            0.04086211,
            0.031077981,
            0.0377884,
            0.031077981
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          90.5,
          91.0,
          91.5,
          92.0,
          93.0,
          94.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 176.0
        },
        {
          "Name": "Study Id",
          "Value": "Gorski 2003"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/12966371"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab 2 & 3"
        },
        {
          "Name": "Grouping",
          "Value": "po Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 52.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Whole Blood"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "4 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.000625164656,
                0.00526336068,
                0.0055206297,
                0.004509666,
                0.00391413458,
                0.003253146,
                0.00285551813,
                0.002936768,
                0.002200273,
                0.001837388,
                0.001221479,
                0.00101237,
                0.0007693714
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.000919034763,
            0.00626682537,
            0.008664772,
            0.008440037,
            0.007907511,
            0.008109928,
            0.00711866,
            0.005932589,
            0.004817403,
            0.00371172326,
            0.00220343587,
            0.001589032,
            0.001131152
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.08,
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 177.0
        },
        {
          "Name": "Study Id",
          "Value": "Gorski 2003"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/12966371"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab 2 & 3"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 52.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Whole Blood"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "6 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.0006707574,
                0.001142521,
                0.00128357986,
                0.001410676,
                0.001140532,
                0.0008191888,
                0.000623611,
                0.000843421847,
                0.00057273556,
                0.0004860608,
                0.000315087935,
                0.000293281919,
                0.000259054883,
                0.0002722952
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.7764297,
            1.735006,
            1.949217,
            1.779459,
            1.624449,
            1.285738,
            0.9788297,
            1.004222,
            0.8157427,
            0.6710513,
            0.6124045,
            0.5103692,
            0.5034657,
            0.353773
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.08,
          132.25,
          132.5,
          132.75,
          133.0,
          133.25,
          133.5,
          133.75,
          134.0,
          134.5,
          135.0,
          135.5,
          136.0,
          138.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 178.0
        },
        {
          "Name": "Study Id",
          "Value": "Gorski 2003"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/12966371"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab 2 & 3"
        },
        {
          "Name": "Grouping",
          "Value": "iv Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 52.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Whole Blood"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "0.05 mg/kg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.003681938,
                0.012005399,
                0.01431668,
                0.008916349,
                0.007024572,
                0.01357058,
                0.009450476,
                0.007590396,
                0.00529699,
                0.005010053,
                0.005476529,
                0.002105015,
                0.001690433
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.016341269,
            0.03163564,
            0.04292583,
            0.02673086,
            0.02257734,
            0.0181321912,
            0.01558304,
            0.0125149693,
            0.01112563,
            0.008644944,
            0.006288098,
            0.00399441272,
            0.00305699115
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.08,
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 179.0
        },
        {
          "Name": "Study Id",
          "Value": "Gorski 2003"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/12966371"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab 2 & 3"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 52.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Whole Blood"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "0.05 mg/kg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                1.90735E-09,
                0.0005772781,
                0.02033237,
                0.00388854765,
                0.003699551,
                0.002970217,
                0.002420693,
                0.002381015,
                0.003962828,
                0.00223352015,
                0.00141242694,
                0.00137296494,
                0.00124872907,
                0.0007946161
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|ObservedData|Peripheral Venous Blood|Whole Blood|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            28.57978,
            33.86706,
            23.34544,
            14.53772,
            11.09241,
            8.904593,
            7.780228,
            6.683517,
            6.251137,
            4.691641,
            3.964251,
            3.40683,
            1.736584,
            1.200623
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.25,
          132.5,
          132.75,
          133.0,
          133.25,
          133.5,
          133.75,
          134.0,
          134.5,
          135.0,
          135.5,
          136.0,
          138.0,
          140.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 214.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2006"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/16432272"
        },
        {
          "Name": "Source",
          "Value": "Methods"
        },
        {
          "Name": "Grouping",
          "Value": "Control pre-Rifampicin (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 19.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "8 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "8 mg, Bedford Laboratories"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                "NaN",
                0.009608088,
                0.01022137,
                0.009539949,
                0.00701865,
                0.00572401658,
                0.00490630371,
                0.002589349,
                0.001908006,
                0.001839774,
                0.00136286207
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77,
            "LLOQ": 1E-10
          },
          "Values": [
            5.00000024E-05,
            0.02200745,
            0.02336745,
            0.02459116,
            0.02084052,
            0.0172913615,
            0.0139467092,
            0.008279475,
            0.005474252,
            0.003895693,
            0.002930243
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0,
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 215.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2006"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/16432272"
        },
        {
          "Name": "Source",
          "Value": "Methods"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 19.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "8 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 146.0
        },
        {
          "Name": "Formulation",
          "Value": "8 mg, Bedford Laboratories"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                "NaN",
                0.002589438,
                0.002521295,
                0.001022147,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77,
            "LLOQ": 1E-10
          },
          "Values": [
            0.05,
            2.927381,
            3.060806,
            2.035798,
            1.487791,
            1.345871,
            0.8632354,
            0.3747871,
            0.2954656,
            0.1477328,
            0.1363756
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          146.0,
          146.25,
          146.5,
          146.75,
          147.0,
          147.5,
          148.0,
          149.0,
          150.0,
          151.0,
          152.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 220.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2008a"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17495878"
        },
        {
          "Name": "Source",
          "Value": "Methods"
        },
        {
          "Name": "Grouping",
          "Value": "Control pre-Rifampicin (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "8 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "8 mg, Bedford Laboratories"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.01347522,
                0.01595749,
                0.0148936594,
                0.01507067,
                0.0154255806,
                0.00921959151,
                0.00514215,
                0.00354611,
                0.002304971,
                0.002482276
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.028183952,
            0.03739651,
            0.03242463,
            0.0260343086,
            0.02548744,
            0.0199763216,
            0.01125846,
            0.007860348,
            0.00517116627,
            0.00443263724
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 221.0
        },
        {
          "Name": "Study Id",
          "Value": "Gurley 2008a"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17495878"
        },
        {
          "Name": "Source",
          "Value": "Methods"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "8 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 146.0
        },
        {
          "Name": "Formulation",
          "Value": "8 mg, Bedford Laboratories"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.00443263724,
                0.00265958183,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            5.134239,
            3.708469,
            2.814615,
            2.098066,
            1.728509,
            1.181646,
            0.6204227,
            0.5908229,
            0.3839177,
            0.1773055
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          146.25,
          146.5,
          146.75,
          147.0,
          147.5,
          148.0,
          149.0,
          150.0,
          151.0,
          152.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 276.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9232132"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "typical representative"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 120.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            14.16216,
            10.78158,
            6.247625,
            5.939787,
            3.963446,
            3.141607,
            3.139376,
            2.116674,
            1.561674
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.25,
          120.5,
          121.05,
          121.116669,
          121.816666,
          122.05,
          122.55,
          123.05,
          124.033333
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 279.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15536460"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "iv Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.0226,
            0.0158999991,
            0.00945,
            0.00675,
            0.00413,
            0.00373999984,
            0.0033,
            0.00271,
            0.00232,
            0.00161,
            0.00131,
            0.00112,
            0.00081,
            0.0007,
            0.00051
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0833333358,
          0.25,
          0.5,
          1.0,
          1.5,
          1.75,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          7.0,
          8.0,
          9.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 280.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15536460"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 104.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                "NaN",
                0.00258,
                0.00192999991,
                0.00112,
                0.00078,
                0.00055,
                0.00041,
                0.000450000021,
                0.0003,
                0.000200000009,
                0.000200000009,
                0.000100000005,
                0.000100000005,
                0.000100000005
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            13.1,
            9.72,
            6.12,
            3.54,
            3.07,
            2.35,
            1.61,
            1.44,
            1.22,
            1.0,
            0.71,
            0.51,
            0.4,
            0.3
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          104.083336,
          104.25,
          104.5,
          104.75,
          105.0,
          105.25,
          105.75,
          106.0,
          106.5,
          107.0,
          107.5,
          108.0,
          109.0,
          110.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 285.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15536460"
        },
        {
          "Name": "Source",
          "Value": "Fig. 4"
        },
        {
          "Name": "Grouping",
          "Value": "po #1 Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Solution"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.00205999985,
                0.00405,
                0.00366000016,
                0.00116,
                0.00217000023,
                0.00105,
                0.00097,
                0.00089,
                0.00067,
                0.00078,
                0.00059,
                0.00038,
                0.00039,
                0.00027,
                0.00031,
                0.00028
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.00199999986,
            0.00506,
            0.00744000031,
            0.00617,
            0.00575,
            0.00439,
            0.00397,
            0.00358,
            0.00269,
            0.0025,
            0.00169000006,
            0.00131,
            0.00111,
            0.00092,
            0.00069,
            0.00061
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0833333358,
          0.25,
          0.5,
          1.0,
          1.25,
          1.5,
          1.75,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          7.0,
          8.0,
          9.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 286.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2004"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15536460"
        },
        {
          "Name": "Source",
          "Value": "Fig. 4"
        },
        {
          "Name": "Grouping",
          "Value": "po #1 with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 128.0
        },
        {
          "Name": "Formulation",
          "Value": "Solution"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.722,
            1.03,
            0.833,
            0.528,
            0.444,
            0.444,
            0.332999974,
            0.332999974,
            0.222,
            0.193999991,
            0.139,
            0.111,
            0.111
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          128.083328,
          128.25,
          128.5,
          129.0,
          129.25,
          129.5,
          129.75,
          130.0,
          130.5,
          131.0,
          132.0,
          133.0,
          134.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 293.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "iv Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.02874158,
                0.00661397446,
                0.003490145,
                0.002461803,
                0.00194341387,
                0.001855472,
                0.001549582,
                0.001349989,
                0.00113199791,
                0.0008010316,
                0.000900100742,
                0.0006736665,
                0.00089060684,
                0.0005934198,
                0.00047508048,
                0.0005961453,
                0.000407580927,
                0.00052333757,
                0.0004446983,
                0.0004364775
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.061621327,
            0.02618743,
            0.02044153,
            0.01441864,
            0.01138242,
            0.009399509,
            0.007849926,
            0.00733712129,
            0.006630036,
            0.0055370233,
            0.004892001,
            0.004273728,
            0.003733594,
            0.003225206,
            0.00240667886,
            0.00192140392,
            0.001450004,
            0.001355281,
            0.00110664894,
            0.0009036291
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0,
          0.08,
          0.17,
          0.33,
          0.5,
          0.75,
          1.0,
          1.17,
          1.25,
          1.5,
          1.75,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          7.0,
          8.0,
          9.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 294.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin @ 5 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 108.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            5.148736,
            4.549165,
            3.97430229,
            3.245926,
            3.001392,
            2.166628,
            1.636237,
            1.263898,
            1.00993,
            0.8932651,
            0.682251
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          109.5,
          109.75,
          110.0,
          110.5,
          111.0,
          112.0,
          113.0,
          114.0,
          115.0,
          116.0,
          117.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 295.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin @ 10 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 108.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            66.61198,
            17.98876,
            12.68082,
            9.673684,
            8.169871,
            6.746292,
            6.521905,
            6.377112,
            5.761923,
            5.207179,
            4.600803,
            4.111183,
            3.395775,
            2.901513,
            2.479148,
            2.00203,
            1.711804,
            1.367809,
            1.169544,
            0.94512707
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          108.0,
          108.08,
          108.17,
          108.33,
          108.5,
          108.75,
          109.0,
          109.17,
          109.25,
          109.5,
          109.75,
          110.0,
          110.5,
          111.0,
          111.5,
          112.0,
          113.0,
          114.0,
          115.0,
          116.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 296.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin @ 25 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 108.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            53.83334,
            22.6216,
            15.2536592,
            11.00436,
            8.68711,
            7.173741,
            5.59972,
            4.947394,
            4.624201,
            3.861865,
            3.411987,
            3.04865,
            2.379732,
            2.055694,
            1.622815,
            1.340107,
            1.022775,
            0.7462093,
            0.6592816
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          108.0,
          108.08,
          108.17,
          108.33,
          108.5,
          108.75,
          109.0,
          109.17,
          109.25,
          109.5,
          109.75,
          110.0,
          110.5,
          111.0,
          111.5,
          112.0,
          113.0,
          114.0,
          115.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 297.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin @ 75 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 108.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            81.65456,
            26.48396,
            16.31977,
            10.51974,
            7.849926,
            6.338055,
            5.06007,
            4.783069,
            4.420555,
            4.273728,
            3.450621,
            3.04865,
            2.754849,
            2.19937,
            1.987415,
            1.483027,
            1.15763,
            0.9242089,
            0.644601
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          108.0,
          108.08,
          108.17,
          108.33,
          108.5,
          108.75,
          109.0,
          109.08,
          109.17,
          109.25,
          109.5,
          109.75,
          110.0,
          110.5,
          111.0,
          111.5,
          112.0,
          113.0,
          114.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 303.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2A"
        },
        {
          "Name": "Grouping",
          "Value": "po Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                3.86847023E-05,
                3.868484E-05,
                0.004177949,
                0.00599613274,
                0.004874278,
                0.005415863,
                0.002901354,
                0.00270793,
                0.002398453,
                0.002359767,
                0.002359768,
                0.00189555192,
                0.001624758,
                0.00170212809,
                0.001199226,
                0.001276596,
                0.000967118249,
                0.00069632486,
                0.0006576406,
                0.0005029012,
                0.000425531878
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.000232108287,
            0.003288201,
            0.007388782,
            0.01148936,
            0.0140425507,
            0.0126499,
            0.008433268,
            0.0080851065,
            0.0075435196,
            0.007079304,
            0.006576402,
            0.005725338,
            0.00495164376,
            0.00398452627,
            0.003365571,
            0.003172147,
            0.002591876,
            0.00193423615,
            0.001470019,
            0.001276596,
            0.000889748568
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0,
          0.17,
          0.25,
          0.33,
          0.5,
          0.75,
          1.0,
          1.17,
          1.25,
          1.33,
          1.5,
          1.75,
          2.0,
          2.5,
          3.0,
          3.5,
          4.0,
          5.0,
          6.0,
          7.0,
          9.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 304.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2A"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin @ 5 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.1160542,
            1.160542,
            4.487427,
            7.388782,
            9.632495,
            10.56093,
            9.245648,
            6.847195,
            6.344294,
            6.073501,
            5.764023,
            5.222437,
            4.410058,
            4.061895,
            3.288201,
            2.940039,
            2.359768,
            1.89555109,
            1.431335,
            1.083172,
            0.9284332,
            0.5415861
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.0,
          132.08,
          132.17,
          132.25,
          132.33,
          132.5,
          132.75,
          133.08,
          133.17,
          133.25,
          133.33,
          133.5,
          133.75,
          134.0,
          134.5,
          135.0,
          135.5,
          136.0,
          137.0,
          138.0,
          139.0,
          141.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 305.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2A"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin @ 10 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.07736944,
            1.431335,
            5.647969,
            9.052224,
            10.40619,
            10.40619,
            8.007737,
            5.918762,
            5.5706,
            5.261122,
            4.874275,
            4.332689,
            3.636364,
            3.249516,
            2.553191,
            2.243714,
            1.740812,
            1.431335,
            1.083172,
            0.8123791,
            0.6576402,
            0.5802708
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.0,
          132.08,
          132.17,
          132.25,
          132.33,
          132.5,
          132.75,
          133.08,
          133.17,
          133.25,
          133.33,
          133.5,
          133.75,
          134.0,
          134.5,
          135.0,
          135.5,
          136.0,
          137.0,
          138.0,
          139.0,
          140.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 306.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2A"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin @ 25 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.07722007,
            1.158301,
            3.127413,
            5.289575,
            6.409266,
            6.563706,
            5.057915,
            3.783784,
            3.436293,
            3.204633,
            2.972973,
            2.586873,
            2.239382,
            2.046332,
            1.814672,
            1.621622,
            1.351351,
            1.042471,
            0.8880309,
            0.6177606,
            0.4633205,
            0.4247104
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.0,
          132.08,
          132.17,
          132.25,
          132.33,
          132.5,
          132.75,
          133.08,
          133.17,
          133.25,
          133.33,
          133.5,
          133.75,
          134.0,
          134.25,
          134.5,
          135.0,
          135.5,
          136.0,
          137.0,
          138.0,
          139.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 307.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21562488"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2A"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin @ 75 mg)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "3 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.03861004,
            1.389961,
            3.89961386,
            3.706564,
            3.745174,
            3.89961386,
            3.166023,
            2.586873,
            2.548263,
            2.200772,
            2.007722,
            1.776062,
            1.505792,
            1.274131,
            1.235521,
            1.042471,
            1.042471,
            0.8880309,
            0.6563706,
            0.6177606,
            0.3474903,
            0.2316602
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.0,
          132.08,
          132.17,
          132.25,
          132.33,
          132.5,
          132.75,
          133.08,
          133.17,
          133.25,
          133.33,
          133.5,
          133.75,
          134.0,
          134.25,
          134.5,
          134.75,
          135.0,
          135.5,
          136.0,
          137.0,
          138.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 341.0
        },
        {
          "Name": "Study Id",
          "Value": "Link 2008"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/18537963"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab.1"
        },
        {
          "Name": "Grouping",
          "Value": "iv Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "2 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.0880812258,
                0.0125105111,
                0.006980721,
                0.00457891729,
                0.00287832483,
                0.003610662,
                0.002920249,
                0.00191814406,
                0.001333541,
                0.0007206521,
                0.000587888,
                0.000418629177,
                3.448249E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.1773568,
            0.04757944,
            0.03316938,
            0.02859046,
            0.02571214,
            0.019512929,
            0.01578181,
            0.0119768111,
            0.006336411,
            0.00342422375,
            0.001850466,
            0.00131769711,
            8.528557E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0833333358,
          0.166666672,
          0.333333343,
          0.5,
          0.6666667,
          1.0,
          1.5,
          2.0,
          4.0,
          6.0,
          8.0,
          10.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 342.0
        },
        {
          "Name": "Study Id",
          "Value": "Link 2008"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/18537963"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab.1"
        },
        {
          "Name": "Grouping",
          "Value": "iv with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "2 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 144.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.05287027,
                0.00348241,
                0.00287832483,
                0.00305947079,
                0.00214306917,
                0.001626373,
                0.001389441,
                0.0008563514,
                0.000309211115,
                0.0002411004,
                0.00017749361,
                0.0001141046
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            166.4172,
            39.30701,
            25.71214,
            19.1032,
            15.78181,
            11.97681,
            7.508895,
            5.347005,
            1.930698,
            0.7588996,
            0.2983008,
            0.1718
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          144.083328,
          144.166672,
          144.333328,
          144.5,
          144.666672,
          145.0,
          145.5,
          146.0,
          148.0,
          150.0,
          152.0,
          154.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 343.0
        },
        {
          "Name": "Study Id",
          "Value": "Link 2008"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/18537963"
        },
        {
          "Name": "Source",
          "Value": "Fig. 5, Tab.3"
        },
        {
          "Name": "Grouping",
          "Value": "po Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "7.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum® Hoffmann-LaRoche Ltd"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.01752388,
                0.0226843618,
                0.0212757215,
                0.01674503,
                0.009470755,
                0.007813723,
                0.00691792648,
                0.003469483,
                0.002202336,
                0.001160009,
                0.000896239944,
                0.0006403636,
                9.3616145E-05
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.01205609,
            0.0483564921,
            0.04535368,
            0.03822668,
            0.0271565616,
            0.02240516,
            0.01697065,
            0.0108343493,
            0.00753407925,
            0.003968331,
            0.002045996,
            0.001278582,
            0.0001142891
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.166666672,
          0.333333343,
          0.5,
          0.6666667,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          6.0,
          8.0,
          10.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 344.0
        },
        {
          "Name": "Study Id",
          "Value": "Link 2008"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/18537963"
        },
        {
          "Name": "Source",
          "Value": "Fig. 5, Tab.3"
        },
        {
          "Name": "Grouping",
          "Value": "po with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "7.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 144.0
        },
        {
          "Name": "Formulation",
          "Value": "Dormicum® Hoffmann-LaRoche Ltd"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.000569096941,
                0.00317319017,
                0.00125421409,
                0.001296827,
                0.001773803,
                0.0007635494,
                0.0002678516,
                7.35856E-05,
                3.891035E-05,
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.5556222,
            2.53345,
            1.688022,
            1.583201,
            1.363235,
            0.6592126,
            0.3120323,
            0.1299239,
            0.08294563,
            0.06282664
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          144.166672,
          144.333328,
          144.5,
          144.666672,
          145.0,
          145.5,
          146.0,
          147.0,
          148.0,
          150.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 388.0
        },
        {
          "Name": "Study Id",
          "Value": "Phimmasone 2001"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/11753266"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab.1&2"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "bolus"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.0326392762,
                0.01466147,
                0.00405513169,
                0.00665137731,
                0.004753922,
                0.00341860787,
                0.00337769184,
                0.003866261,
                0.003685795,
                0.003240941,
                0.00358224381,
                0.00290049776,
                0.002275486,
                0.001601458,
                0.001909692,
                0.00138455292,
                0.000564341433,
                0.0006479579,
                0.0006103216
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.088439934,
            0.04364608,
            0.0241063181,
            0.0211012177,
            0.01415264,
            0.009784649,
            0.009488017,
            0.009106511,
            0.008563273,
            0.007970452,
            0.00780733628,
            0.006831773,
            0.006165917,
            0.004970392,
            0.004767931,
            0.002913667,
            0.002075948,
            0.00189086189,
            0.00141797191
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0333333351,
          0.0833333358,
          0.166666672,
          0.25,
          0.5,
          1.0,
          1.08333337,
          1.16666663,
          1.25,
          1.33333337,
          1.5,
          1.83333337,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 389.0
        },
        {
          "Name": "Study Id",
          "Value": "Phimmasone 2001"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/11753266"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1, Tab.1&2"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 106.0
        },
        {
          "Name": "Formulation",
          "Value": "bolus"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.02347605,
                0.02480022,
                0.0136832995,
                0.00222813012,
                0.00152427494,
                0.00154402491,
                0.001334861,
                0.001376112,
                0.001004345,
                0.001268533,
                0.001071198,
                0.001270571,
                0.0007861259,
                0.0005941048,
                0.0007357819,
                0.0005192244,
                0.000746633857,
                0.000498960842,
                0.000437388982
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            71.33704,
            39.40207,
            23.37993,
            14.7505,
            11.41934,
            7.65897465,
            4.779969,
            4.682834,
            4.448874,
            3.854545,
            3.737611,
            3.443009,
            2.891951,
            2.832767,
            2.503824,
            1.766891,
            1.208419,
            0.8180354,
            0.7762349
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          106.033333,
          106.066666,
          106.083336,
          106.166664,
          106.25,
          106.5,
          107.0,
          107.083336,
          107.166664,
          107.25,
          107.333336,
          107.5,
          107.833336,
          108.0,
          108.5,
          109.0,
          110.0,
          111.0,
          112.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 392.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1a"
        },
        {
          "Name": "Grouping",
          "Value": "Week 0 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "2 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 648.0
        },
        {
          "Name": "Formulation",
          "Value": "Syrup"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            1.44951928,
            0.6923077,
            0.21634616
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          649.0,
          650.0,
          652.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 393.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1a"
        },
        {
          "Name": "Grouping",
          "Value": "Week 1 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "2 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 616.0
        },
        {
          "Name": "Formulation",
          "Value": "Syrup"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            3.52644229,
            1.92548084,
            0.6923077,
            0.28125
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          817.0,
          818.0,
          820.0,
          822.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 394.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1a"
        },
        {
          "Name": "Grouping",
          "Value": "Week 2 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "2 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 984.0
        },
        {
          "Name": "Formulation",
          "Value": "Syrup"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            6.1875,
            3.61298084,
            1.4278847,
            0.6923077,
            0.432692319
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          985.0,
          986.0,
          988.0,
          990.0,
          992.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 395.0
        },
        {
          "Name": "Study Id",
          "Value": "Reitman 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21191377"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1a"
        },
        {
          "Name": "Grouping",
          "Value": "Week 4 after Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 11.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "2 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 1320.0
        },
        {
          "Name": "Formulation",
          "Value": "Syrup"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            8.415866,
            4.5,
            1.81730771,
            0.865384638,
            0.5192308,
            0.237980768
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          1321.0,
          1322.0,
          1324.0,
          1326.0,
          1328.0,
          1332.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 421.0
        },
        {
          "Name": "Study Id",
          "Value": "Szalat 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17553741"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 3.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "0.05 mg/kg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "bolus, 1% midazolam (Rafa Ltd., Israel)"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "Arith. SEM converted to arith. SD"
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.0354878381,
                0.0189124513,
                0.0102648316,
                0.007822184,
                0.005941331,
                0.00305279158,
                0.00493148668,
                0.003595687
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.06826481,
            0.06508359,
            0.03850279,
            0.02691856,
            0.0163092986,
            0.0155492593,
            0.01,
            0.008666103
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.0833333358,
          0.25,
          0.5,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 422.0
        },
        {
          "Name": "Study Id",
          "Value": "Szalat 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17553741"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "with Perpetrator (Rifampicin)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 3.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "0.05 mg/kg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 132.0
        },
        {
          "Name": "Formulation",
          "Value": "bolus, 1% midazolam (Rafa Ltd., Israel)"
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "Arith. SEM converted to arith. SD"
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 325.77
              },
              "Values": [
                0.0248905588,
                0.008400042,
                0.00728182029,
                0.00497092167,
                0.00464591244,
                0.002976836,
                0.0009711517,
                0.00130689959
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            73.33056,
            34.58279,
            25.059,
            17.10648,
            9.420918,
            8.770113,
            4.946528,
            3.850279
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          132.083328,
          132.25,
          132.5,
          133.0,
          133.5,
          134.0,
          134.5,
          135.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 275.0
        },
        {
          "Name": "Study Id",
          "Value": "Kharasch 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9232132"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Control (Perpetrator Placebo)"
        },
        {
          "Name": "Data type",
          "Value": "typical representative"
        },
        {
          "Name": "N",
          "Value": 9.0
        },
        {
          "Name": "Molecule",
          "Value": "Midazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "IV"
        },
        {
          "Name": "Dose",
          "Value": "1 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "."
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Midazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 325.77
          },
          "Values": [
            0.02807617,
            0.02201741,
            0.01424062,
            0.007675129,
            0.006201037,
            0.004860217,
            0.003732899,
            0.00253738579,
            0.00188920787,
            0.001572301,
            0.001256607
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.25,
          0.5,
          1.2166667,
          2.1833334,
          3.1833334,
          4.16666651,
          5.1833334,
          7.16666651,
          9.183333,
          11.166667,
          13.166667
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    }
  ],
  "ObservedDataClassifications": [
    {
      "Name": "Backman 1996",
      "Classifiables": [
        "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
        "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)"
      ]
    },
    {
      "Name": "Backman 1998",
      "Classifiables": [
        "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
        "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
        "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)"
      ]
    },
    {
      "Name": "Chung 2006",
      "Classifiables": [
        "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
        "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)"
      ]
    },
    {
      "Name": "Eap 2004",
      "Classifiables": [
        "Eap 2004 - 75 micg Control (Perpetrator Placebo) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=21)",
        "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
        "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
        "Eap 2004 - 75 micg with Perpetrator (Rifampicin) - Midazolam - PO - 75 Âµg - Plasma - agg. (n=4)"
      ]
    },
    {
      "Name": "Gorski 2003",
      "Classifiables": [
        "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
        "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)",
        "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
        "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)"
      ]
    },
    {
      "Name": "Gurley 2006",
      "Classifiables": [
        "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
        "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)"
      ]
    },
    {
      "Name": "Gurley 2008a",
      "Classifiables": [
        "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
        "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)"
      ]
    },
    {
      "Name": "Kharasch 1997",
      "Classifiables": [
        "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
        "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)"
      ]
    },
    {
      "Name": "Kharasch 2004",
      "Classifiables": [
        "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
        "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
        "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
        "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)"
      ]
    },
    {
      "Name": "Kharasch 2011",
      "Classifiables": [
        "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
        "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)"
      ]
    },
    {
      "Name": "Link 2008",
      "Classifiables": [
        "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
        "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
        "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
        "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)"
      ]
    },
    {
      "Name": "Phimmasone 2001",
      "Classifiables": [
        "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
        "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)"
      ]
    },
    {
      "Name": "Reitman 2011",
      "Classifiables": [
        "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
        "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)"
      ]
    },
    {
      "Name": "Szalat 2007",
      "Classifiables": [
        "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
        "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)"
      ]
    }
  ],
  "SimulationClassifications": [
    {
      "Name": "Backman 1996",
      "Classifiables": [
        "DDI Control - Midazolam - Backman 1996",
        "DDI Treatment - Rifampicin/Midazolam - Backman 1996"
      ]
    },
    {
      "Name": "Backman 1998",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
        "DDI Control - Midazolam - Backman 1998"
      ]
    },
    {
      "Name": "Chung 2006",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
        "DDI Control - Midazolam - Chung 2006"
      ]
    },
    {
      "Name": "Eap 2004",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
        "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
        "DDI Control - Midazolam - Eap 2004 (7.5 mg)"
      ]
    },
    {
      "Name": "Gorski 2003",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
        "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
        "DDI Control - Midazolam - Gorski 2003 (iv)",
        "DDI Control - Midazolam - Gorski 2003 (po)"
      ]
    },
    {
      "Name": "Gurley 2006",
      "Classifiables": [
        "DDI Control - Midazolam - Gurley 2006",
        "DDI Treatment - Rifampicin/Midazolam - Gurley 2006"
      ]
    },
    {
      "Name": "Gurley 2008",
      "Classifiables": [
        "DDI Control - Midazolam - Gurley 2008",
        "DDI Treatment - Rifampicin/Midazolam - Gurley 2008"
      ]
    },
    {
      "Name": "Kharasch 2004",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
        "DDI Control - Midazolam - Kharasch 2004 (iv)",
        "DDI Control - Midazolam - Kharasch 2004 (po)"
      ]
    },
    {
      "Name": "Link 2008",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
        "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
        "DDI Control - Midazolam - Link 2008 (po)",
        "DDI Control - Midazolam - Link 2008 (iv)"
      ]
    },
    {
      "Name": "Phimmasone 2001",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
        "DDI Control - Midazolam - Phimmasone 2001"
      ]
    },
    {
      "Name": "Reitman 2011",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Reitman 2011"
      ]
    },
    {
      "Name": "Szalat 2007",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
        "DDI Control - Midazolam - Szalat 2007"
      ]
    },
    {
      "Name": "Kharasch 2011",
      "Classifiables": [
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
        "DDI Control - Midazolam - Kharasch 2011 (iv)",
        "DDI Control - Midazolam - Kharasch 2011 (po)"
      ]
    },
    {
      "Name": "Kharasch 1997",
      "Classifiables": [
        "DDI Control - Midazolam - Kharasch 1997",
        "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997"
      ]
    }
  ]
}